Skip Navigation
Bookmark and Share

Previous Seminars

Driving Biomedical Innovation by Advancing Regulatory Science
Frank F. Weichold, MD, PhD

How to Make Healthcare Data Exchange Work
Kenneth Park, MD

Turning Public Health Data into Action: Preventing Medication Overdoses in Young Children, Developments over a Decade
Daniel Budnitz, MD, MPH, CAPT USPHS

A Case for Why Health Systems Should Partner with Pharmacies
William Shrank, MD, MSHS

21st Century Cures Act: A Requiem for a Dying Piece of Legislation
Aaron Kesselheim, MD, JD, MPH

Propensity Score Methods in Pharmacoepidemiology with Emphasis on Variable Selection and Balance Measures
M. Sanni Ali, PhD

Expanding Role of Epidemiology in the Pharmaceutical Industry with Post-Authorization Safety Studies
Nancy Santanello, MD, MS, FISPE

Confounding in Pharmacoepidemiology: I Know It When I See It
John W. Jackson, ScD

Pharmacoepidemiology and the Regulation of Medicines
Gerald J. Dal Pan, MD, MHS

Open Access to Trials Data: Will It Give Us All That We Need?
Evan Mayo-Wilson, DPhil, MPA

Putting Pharmacoepidemiology into Practice
Panel of Core Faculty

Comparative Effectiveness of Intravenous Iron Formulations in Hemodialysis Patients
M. Alan Brookhart, PhD

Digiceuticals "We don't make the drug, we make the drug work better": Fact or Fiction or Too Soon to Tell?
Caroline Popper, MD, MPH

FDA as a Public Health Agency
Joshua Sharfstein, MD

Managing a Complex Medical/Legal/Scientific Organization for the Public Benefit
Janet Woodcock, MD

Medication Safety: Lessons Learned from a National Medication Error Reporting Program
Michael Cohen, RPh, MS

The Future for Drug Development in an Increasingly Evidence-Based Environment
Jonothan C. Tierce, C.Phil

Driving Innovation in Big Pharma
Robert Carr, MD, MPH

Big Data meets Real World Data and the Future of Comparative Effectiveness Research
Marc Berger, MD

The Two Way Mirror: Reflections on Life in Academic and Industrial Research
Craig Smith, MD

The Trillion Dollar Market for Medicines: Characteristics, Dynamic and Outlook
Murray Aitken, MBA

Approaches to Studying Medication Safety in Children: The Case of Leukotriene-Modifying Agents and Suicide
Glen Schumock, PharmD, MBA, PhD

PAY ATTENTION: Covering Trends in ADHD Medication Among American Youth
Alan Schwarz

Comparative Harms of Anti-Epilepsy Medications
Sean Sullivan, PhD, BScPharm

Regulatory Statistics in FDA's Center for Drug Evaluation and Research
Lisa LaVanve, PhD

Studying the Clinical Importance of Drug-Drug Interactions
Sean Hennessey, PharmD, PhD

Prescription Opioid Poisonings and State Prescription Drug Monitoring Programs
Michael Kim, MPH

Barriers to Delivery of Pharmacologic Venous Thromboembolism Prophylaxis
Stacy Elder, PharmD, BCPS

Diuretic Use, Urate Handling Genes, and Gout
Mara McAdams DeMarco, PhD

Insight into the Drug Use Evaluation (DUE) Process: Assessment of Dabigatran at Johns Hopkins
Emily Pherson, PharmD and Raymond Lamore, PharmD

Safety of the Novel Anticoagulants VS Warfarin: A Comparative Evaluation
Sonal Singh, MD, MPH, PhD Candidate

Patterns of Concomitant Antipsychotic Use Among Youth in Foster Care: Issues of Quality of Care and Safety
Susan dosReis, PhD

Partnership in Applied Comparative Effectiveness Science Initiative: Hopkins and FDA
Jodi Segal, PhD, MPH

Ambulatory Treatment of Pain and Opioids: New Challenges for Drug Safety
G. Caleb Alexander, MD, MS

Impact of 2012 Fungal Meningitis Outbreak Upon Patients who were Exposed but did not Develop Infection
Shmuel Shoham, MD

The Healthy User Effect: Ubiquitous and Uncontrollable
Sumit Majumdar, MD, MPH

Responding to the Joint Commission Alert on Safe Use of Opioids in Hospitals
Suzanne Nesbit, PharmD

Role of the Pharmacy & Therapeutics Committee in the Academic Medical Center
Brent Petty, MD

johns hopkins

  • Receive our Johns Hopkins
    Public Health Magazine,
    Public Health News